Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the Muscular Dystrophy Coordinating Committee (MDCC).

The meeting will be open to the public and accessible by teleconference. Participation is limited to space available. Individuals who plan to participate and need special assistance, such as reasonable accommodations, should notify the Contact Person listed below in advance of the meeting.

*Name of Committee:*                         Muscular Dystrophy Coordinating Committee.                    

*Type of meeting:*                         Open Meeting.                    

*Date:*                         September 17, 2018.                    

*Time:*                         2:00 p.m. to 5:00 p.m. *Eastern Time*—Approximate end time.                    

*Agenda:*                         The purpose of this meeting is to bring together committee members, representing government agencies, patient advocacy groups, other voluntary health organizations, and patients and their families to update one another on progress relevant to the Action Plan for the Muscular Dystrophies and to coordinate activities and discuss gaps and opportunities leading to better understanding of the muscular dystrophies, advances in treatments, and improvements in patients' and their families' lives. Prior to the meeting, an agenda will be posted to the MDCC website:                         *https://mdcc.nih.gov/​.*

*Registration:*                         To register, please contact Emily Carifi:                         *Emily.Carifi@nih.gov.*

*WebEx/Phone Access:*

*Join WebEx Meeting: https://nih.webex.com/​nih/​j.php?​MTID=​m1c5fd34513186c7c87ebeeee5af47f05;​*

*Meeting number (access code):*                         628 888 923, Meeting password: fEN63PND                    

*Join by Phone:*                         1-650-479-3208 Call-in toll number (US/Canada)                    

*Global call-in numbers: https://nih.webex.com/​nih/​globalcallin.php?​serviceType=​MC&​ED=​701170342&​tollFree=​0.*
      ( print page 37821)    
*Place:*                         National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852, (Telephone Conference Call).                    

*Contact Person:*                         Glen H. Nuckolls, Ph.D., Executive Secretary, Muscular Dystrophy Coordinating Committee, National Institute of Neurological Disorders and Stroke, NIH, 6001 Executive Boulevard, NSC 2203, Bethesda, MD 20892, (301) 496-5745,                         *glen.nuckolls@nih.gov.*

Any member of the public interested in presenting oral comments to the committee may notify the Contact Person listed on this notice at least 10 days in advance of the meeting. Interested individuals and representatives of organizations may submit a letter of intent, a brief description of the organization represented, and a short description of the oral presentation. Only one representative of an organization may be allowed to present oral comments and if accepted by the committee, presentations may be limited to five minutes. Both printed and electronic copies are requested for the record. In addition, any interested person may file written comments with the committee by forwarding their statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person.

                        More information can be found on the Muscular Dystrophy Coordinating Committee home page:                         *https://mdcc.nih.gov/​.*

(Catalogue of Federal Domestic Assistance Program Nos. 93.853, Clinical Research Related to Neurological Disorders; 93.854, Biological Basis Research in the Neurosciences, National Institutes of Health, HHS)

Dated:  July 27, 2018. 

Sylvia L. Neal, 

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2018-16505 Filed 8-1-18; 8:45 am]

 BILLING CODE 4140-01-P